How many insider declarations has Cole, Ryan filed?

Cole, Ryan has filed 4 public insider declarations with SEC (Form 4).

What is Cole, Ryan's role?

Cole, Ryan's reported role is not specified by the regulator across the filings.

Which companies does Cole, Ryan report trades for?

Cole, Ryan reports trades for Aurinia Pharmaceuticals Inc..

← Executives ★ Sign in to follow

CR

Cole, Ryan

OFFICER

·SEC (Form 4)

Aurinia Pharmaceuticals Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Discover the detailed record of transactions filed by Cole, Ryan. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Cumulatively, 4 reports have been logged. Activity tracked since 18 May 2026. The latest transaction was filed on 18 May 2026 (50 - Grant of options). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Cole, Ryan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Aurinia Pharmaceuticals Inc. (US)

申报4 总计

●

Cole, Ryan

5 - Senior Officer of Issuer高管2026年5月18日Aurinia Pharmaceuticals Inc.

13SEDI ↗

116,144 股Rights Performance AwardTSXSEDI:4724313

●

Cole, Ryan

5 - Senior Officer of Issuer高管2026年3月23日Aurinia Pharmaceuticals Inc.

13SEDI ↗

Rights Performance AwardTSXSEDI:4724311

◇

Cole, Ryan

5 - Senior Officer of Issuer高管2026年5月18日Aurinia Pharmaceuticals Inc.

CA$107万27SEDI ↗

70,230 股@ CA$15.280.081% mcap100.0% 占其流量OptionsTSXSEDI:4724310

●

Cole, Ryan

5 - Senior Officer of Issuer高管2026年3月23日Aurinia Pharmaceuticals Inc.

13SEDI ↗

OptionsTSXSEDI:4724307

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

CR

Cole, Ryan

OFFICER

·SEC (Form 4)

Aurinia Pharmaceuticals Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

Discover the detailed record of transactions filed by Cole, Ryan. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Cumulatively, 4 reports have been logged. Activity tracked since 18 May 2026. The latest transaction was filed on 18 May 2026 (50 - Grant of options). Regulator: SEC (Form 4). The full history is accessible without signup.